Nerinetide

Unassigned

New Medicines

Acute ischaemic stroke in patients undergoing endovascular thrombectomy

Information

New molecular entity
NoNO
Arbor Vita Corporation

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

PSD-95 inhibitor (Signal transduction pathway inhibitor) - new in class
Stroke occurs approximately 152,000 times a year in the UK; that is one every 3 minutes 27 seconds. By the age of 75, 1 in 5 women and 1 in 6 men will have a stroke. 1 in 8 strokes are fatal within the first 30 days and 1 in 4 strokes are fatal within a year [6].
Acute ischaemic stroke in patients undergoing endovascular thrombectomy
Intravenous

Evidence based evaluations